{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:15:50Z","timestamp":1783646150005,"version":"3.55.0"},"reference-count":39,"publisher":"American Society for Microbiology","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2014,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Because of the increasing bacterial resistance of uropathogens against standard antibiotics, such as trimethoprim (TMP), older antimicrobial drugs, such as nitroxoline (NTX), should be reevaluated. This randomized crossover study investigated the urinary concentrations of parent drugs and their metabolites and their antibacterial activities (urinary inhibitory titers [UITs] and urinary bactericidal titers [UBTs]) against uropathogens at three different urinary pH values within 24 h in six healthy volunteers after a single oral dose of NTX at 250 mg versus TMP at 200 mg. In three additional volunteers, urinary bactericidal kinetics (UBK) were studied after oral administration of NTX at 250 mg three times a day. The mean urinary concentrations of NTX and NTX sulfate in 24 h were 0.012 to 0.507 mg\/liter and 0.28 to 27.83 mg\/liter, respectively. The mean urinary concentrations of TMP were 18.79 to 41.59 mg\/liter. The antibacterial activity of NTX was higher in acidic urine than in alkaline urine, and that of TMP was higher in alkaline urine than in acidic urine. The UITs and UBTs of NTX were generally lower than those of TMP except for a TMP-resistant\n            <jats:named-content xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" content-type=\"genus-species\" xlink:type=\"simple\">Escherichia coli<\/jats:named-content>\n            strain, for which NTX showed higher UITs\/UBTs than did TMP. UBK showed mainly bacteriostatic activity of NTX in urine. NTX exhibits mainly bacteriostatic activity and TMP also shows bactericidal activity in urine against susceptible strains. NTX is a more active antibacterial in acidic urine, and TMP is more active in alkaline urine. The cumulative effects of multiple doses or inhibition of bacterial adherence could not be evaluated. (This study has been registered at EudraCT under registration no. 2009-015631-32.)\n          <\/jats:p>","DOI":"10.1128\/aac.02147-13","type":"journal-article","created":{"date-parts":[[2013,11,12]],"date-time":"2013-11-12T04:30:35Z","timestamp":1384230635000},"page":"713-721","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":49,"title":["Urinary Concentrations and Antibacterial Activities of Nitroxoline at 250 Milligrams versus Trimethoprim at 200 Milligrams against Uropathogens in Healthy Volunteers"],"prefix":"10.1128","volume":"58","author":[{"given":"Florian M. E.","family":"Wagenlehner","sequence":"first","affiliation":[{"name":"Department of Urology, Pediatric Urology, and Andrology, Justus Liebig University, Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"M\u00fcnch","sequence":"additional","affiliation":[{"name":"Department of Urology, Pediatric Urology, and Andrology, Justus Liebig University, Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Pilatz","sequence":"additional","affiliation":[{"name":"Department of Urology, Pediatric Urology, and Andrology, Justus Liebig University, Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birte","family":"B\u00e4rmann","sequence":"additional","affiliation":[{"name":"Department of Urology, Pediatric Urology, and Andrology, Justus Liebig University, Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Weidner","sequence":"additional","affiliation":[{"name":"Department of Urology, Pediatric Urology, and Andrology, Justus Liebig University, Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Wagenlehner","sequence":"additional","affiliation":[{"name":"Department of Anesthesia, Justus Liebig University, Giessen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Straubinger","sequence":"additional","affiliation":[{"name":"Eukarion Institute, Department of Microbiology, Nuremburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Blenk","sequence":"additional","affiliation":[{"name":"Eukarion Institute, Department of Microbiology, Nuremburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Pfister","sequence":"additional","affiliation":[{"name":"Institute for Medical Microbiology, University of Jena, Jena, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kresken","sequence":"additional","affiliation":[{"name":"Antiinfectives Intelligence, Campus Hochschule Bonn-Rhein-Sieg, Rheinbach, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt G.","family":"Naber","sequence":"additional","affiliation":[{"name":"Technical University of Munich, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg028"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2011.09.013"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2008.05.010"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1086\/520427"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2004.02106.x"},{"key":"e_1_3_2_7_2","first-page":"34","article-title":"The treatment of acute dysuria-frequency syndrome in adult women: double-blind, randomized comparison of three-day vs ten-day trimethoprim therapy","volume":"37","author":"Gossius GVL","year":"1985","unstructured":"GossiusGVL. 1985. The treatment of acute dysuria-frequency syndrome in adult women: double-blind, randomized comparison of three-day vs ten-day trimethoprim therapy. Curr. Ther. Res. 37:34\u201342.","journal-title":"Curr. Ther. Res."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.3109\/13814780509178238"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(98)00021-1"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2011.09.013"},{"key":"e_1_3_2_11_2","first-page":"1","volume-title":"European Association of Urology guidelines","author":"Grabe M","year":"2011","unstructured":"GrabeMBjerklund JohansenTEBottoHCekMNaberKGTenkePWagenlehnerFME. 2011. Guidelines on urological infections, p 1\u2013112. In EuropeanAssociationofUrology (ed), European Association of Urology guidelines. European Association of Urology, Arnhem, Netherlands."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq257"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2011.0415"},{"key":"e_1_3_2_14_2","first-page":"164","article-title":"S3-guideline for uncomplicated urinary tract infections: treatment guidelines compliance","volume":"34","author":"Wagenlehner FM","year":"2011","unstructured":"WagenlehnerFMSchmiemannGHoymeUFunfstuckRHummers-PradierEKaaseMKniehESelbachISesterUVahlensieckWWatermannDNaberKG. 2011. S3-guideline for uncomplicated urinary tract infections: treatment guidelines compliance. Med. Monatsschr. Pharm. 34:164\u2013168. (In German.)","journal-title":"Med. Monatsschr. Pharm."},{"key":"e_1_3_2_15_2","first-page":"71","article-title":"Treatment of uncomplicated urinary tract infections in women with Nibiol Forte","volume":"94","author":"Frobert J-L","year":"1987","unstructured":"FrobertJ-LCoupryA. 1987. Treatment of uncomplicated urinary tract infections in women with Nibiol Forte. Gaz. M\u00e9d. Fr. 94:71\u201394. (In French.)","journal-title":"Gaz. M\u00e9d. Fr."},{"key":"e_1_3_2_16_2","first-page":"236","article-title":"Therapy for chronically recurrent urinary tract infection","volume":"34","author":"Sachse D","year":"1984","unstructured":"SachseD. 1984. Therapy for chronically recurrent urinary tract infection. Therapiewoche 34:236\u2013238. (In German.)","journal-title":"Therapiewoche"},{"key":"e_1_3_2_17_2","first-page":"429","article-title":"First experience with 5-nitro-oxy-chinolin in the treatment of chronic urinary tract infection","volume":"68","author":"Schlesinger E","year":"1975","unstructured":"SchlesingerEPatschRKraftM. 1975. First experience with 5-nitro-oxy-chinolin in the treatment of chronic urinary tract infection. Zschr. Urol. 68:429\u2013434. (In German.)","journal-title":"Zschr. Urol."},{"key":"e_1_3_2_18_2","first-page":"4294","article-title":"Are gyrase inhibitors invariably superior? Nitroxoline versus norfloxacin: a comparison of treatment","volume":"36","author":"Schuelke J","year":"1986","unstructured":"SchuelkeJ. 1986. Are gyrase inhibitors invariably superior? Nitroxoline versus norfloxacin: a comparison of treatment. Therapiewoche 36:4294\u20134297. (In German.)","journal-title":"Therapiewoche"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.3.707"},{"key":"e_1_3_2_20_2","volume-title":"Abstr. 65th Annu. Meet. German Soc. Hyg. Microbiol.","author":"K\u00f6rber-Irrgang B","year":"2013","unstructured":"K\u00f6rber-IrrgangBKreskenM. 2013. Abstr. 65th Annu. Meet. German Soc. Hyg. Microbiol., Rostock, Germany, poster FTP09."},{"key":"e_1_3_2_21_2","unstructured":"WolfKM. 2013. Antagonism and adhesion of the probiotic E. coli strain Nissle 1917. Master's thesis. Julius Maximilian University of Wuerzburg Wuerzburg Germany. (In German.)"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01484-12"},{"key":"e_1_3_2_23_2","volume-title":"Abstr. 51st Intersci. Conf. Antimicrob. Agents Chemother.","author":"Wagenlehner FME","year":"2011","unstructured":"WagenlehnerFMEMuenchFPilatzABlenkBBlenkHWeidnerWNaberKG. 2011. Urinary antibacterial activity of nitroxolin 250 mg versus trimethoprim 200 mg against uropathogens after single oral administration, poster A2-038. Abstr. 51st Intersci. Conf. Antimicrob. Agents Chemother., Chicago, IL, 17 to 20 September 2011."},{"key":"e_1_3_2_24_2","volume-title":"Approved standard M7-A7","author":"Clinical and Laboratory Standards Institute","year":"2006","unstructured":"Clinical and Laboratory Standards Institute. 2006. Methods for dilution in antimicrobial susceptibility tests for bacteria that grow aerobically; approved guideline-7th ed. Approved standard M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA."},{"key":"e_1_3_2_25_2","volume-title":"Fachinformation Nitroxolin forte 2012","author":"Rosen Pharma GmbH","year":"2012","unstructured":"Rosen Pharma GmbH. 2012. Fachinformation Nitroxolin forte 2012. Rosen Pharma GmbH, Blieskastel, Germany."},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2012.0276"},{"key":"e_1_3_2_27_2","first-page":"482","article-title":"Appropriate nitroxoline dosage regimen design","volume":"17","author":"Karba R","year":"1979","unstructured":"KarbaRMrharAKozjekFBremsakF. 1979. Appropriate nitroxoline dosage regimen design. Int. J. Clin. Pharmacol. Biopharm. 17:482\u2013485.","journal-title":"Int. J. Clin. Pharmacol. Biopharm."},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/33.suppl_A.121"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00477-06"},{"key":"e_1_3_2_30_2","first-page":"873","article-title":"Present status of nitroxoline","volume":"35","author":"Bergogne-Berezin E","year":"1987","unstructured":"Bergogne-BerezinEBerthelotGMuller-SerieysC. 1987. Present status of nitroxoline. Pathol. Biol. (Paris) 35:873\u2013878. (In French.)","journal-title":"Pathol. Biol. (Paris)"},{"key":"e_1_3_2_31_2","first-page":"476","article-title":"Clinical pharmacokinetics of nitroxoline","volume":"17","author":"Mrhar A","year":"1979","unstructured":"MrharAKopitarZKozjekFPreslVKarbaR. 1979. Clinical pharmacokinetics of nitroxoline. Int. J. Clin. Pharmacol. Biopharm. 17:476\u2013481.","journal-title":"Int. J. Clin. Pharmacol. Biopharm."},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2006.07.026"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2005.09.014"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.12.3789-3794.2003"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01133-08"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.20.2207"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01643691"},{"key":"e_1_3_2_38_2","first-page":"451","article-title":"Inhibition of bacterial adherence by nitroxoline on cellular adhesion and on urinary catheter surfaces","volume":"37","author":"Bourlioux P","year":"1989","unstructured":"BourliouxPBottoHKaramDAmgarACameyM. 1989. Inhibition of bacterial adherence by nitroxoline on cellular adhesion and on urinary catheter surfaces. Pathol. Biol. (Paris) 37:451\u2013454. (In French.)","journal-title":"Pathol. Biol. (Paris)"},{"key":"e_1_3_2_39_2","first-page":"452","article-title":"Inhibition of bacterial adhesion of uropathogenic Escherichia coli strains by the urine of patients treated with nitroxoline","volume":"36","author":"Karam D","year":"1988","unstructured":"KaramDAmgarABourliouxP. 1988. Inhibition of bacterial adhesion of uropathogenic Escherichia coli strains by the urine of patients treated with nitroxoline. Pathol. Biol. (Paris) 36:452\u2013455. (In French.)","journal-title":"Pathol. Biol. (Paris)"},{"key":"e_1_3_2_40_2","first-page":"455","article-title":"Direct effect of nitroxoline in the inhibition of bacterial adherence to urinary catheters","volume":"38","author":"Oliviero L","year":"1990","unstructured":"OlivieroLPerdizMBourliouxP. 1990. Direct effect of nitroxoline in the inhibition of bacterial adherence to urinary catheters. Pathol. Biol. (Paris) 38:455\u2013458. (In French.)","journal-title":"Pathol. Biol. (Paris)"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02147-13","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.02147-13","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T22:34:50Z","timestamp":1645482890000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.02147-13"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["10.1128\/AAC.02147-13"],"URL":"https:\/\/doi.org\/10.1128\/aac.02147-13","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"2013-10-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-11-07","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-01-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}